Grant M. Gallagher

A CDC report contains details on the public health efforts being employed to track contacts of people with COVID-19.

A recent report discusses the expansion of pre-exposure prophylaxis into the 35 PEPFAR supported early program adopters from October 2016 to September 2018.

Investigators have shown that a new monoclonal antibody treatment is able to break apart communities of harmful bacteria, which could aid existing antibiotic treatments in more efficiently clearing out infections.

The CDC has taken a concerned tone about the coronavirus but notes risk to Americans is still low at present time.

Public health officials have confirmed several fatalities linked to the novel coronavirus.

The investigators of a new observational cohort study on incidence of tetanus and diphtheria in 31 countries have provided data that suggest no benefit associated with performing adult booster vaccinations.

More than half of patients filled a prescription for an antibiotic within 7 days of a dental-related ED visit. Around 40% of these individuals filled a prescription for an opioid.

While locally-acquired Chagas disease is rare in the United States, the testing of a blood donation sample led to what is likely the first documented case of the disease in Missouri.

In addition to meeting its primary endpoint, cefepime-enmetazobactam displayed superiority over piperacillin-tazobactam alongside a comparable safety profile.

Health officials are investigation an outbreak of E coli in 5 states with a suspected link to clover sprouts served at Jimmy John’s restaurants.

In models of air transportation networks during the early stages of an outbreak, disease spread could be reduced by up to 38% with improved hand washing at 10 major airports.

RESTORE-IMI 1 showed a safety difference IMI-REL and IMI+CST when it comes to nephrotoxicity. The team behind a new retrospective study has applied acute kidney injury assessments to the results.

The US Food and Drug Administration has sent the sandwich chain a warning letter over citing involvement in several outbreaks of Salmonella and Escherichia coli over the past 7 years.

Among a cohort of 9 pregnant women who developed COVID-19 pneumonia, there was no evidence of vertical transmission to infants.

Clinicians accustomed to HIPAA guidelines may not be aware of changes in confidentiality when they make contact with school health care services.

A new study looks at how vancomycin-resistant enterococci spread through contact between patients and health care workers.

Based on data from 4112 children and adults, vaccine effectiveness was estimated to be 37% against influenza A and 50% against influenza B viruses.

Infectious diseases consultations during hospital stays were associated with improved outcomes after discharge in patients with S aureus bacteremia for at least 5 years.

The Advisory Committee on Immunization Practices has announced changes to the 2020 child and adolescent vaccine schedule.

The NIH has begun the first clinical trial evaluating the safety of a monthly dapivirine ring used to prevent HIV among pregnant women in eastern and southern Africa.

A commentary agrees with World Health Organization recommendations against routine use of corticosteroids in treatment of COVID-19.

A new study has identified that misinformation and limited clinician communication around HPV risk among young men who have sex with men some of the barriers to HPV vaccination.

Pneumococcal conjugate vaccines have been effective at reducing pneumonia, sepsis, and bacteremia in immunized populations. Pneumococcal meningitis, however, remains a significant challenge.

The International Health Regulations Emergency Committee decided today that the Ebola outbreak in the Democratic Republic of the Congo remains a PHEIC.

A new article examines pregnancy outcomes among women who received the rVSV-ZEBOV vaccine in the STRIVE study.

Less than 1 in 4 teenage boys considered at-risk ever received an HIV test in a recent study.

A new retrospective study provides more evidence that a single HPV vaccine dose may be effective in preventing cervical cancer.

The PRIMVAC placental malaria vaccine candidate was found to be safe and immunogenic.

A phase 1 clinical trial suggests that the m102.4 antibody is well tolerated and safe for use as a treatment against henipaviruses.

Screening for 2019 novel coronavirus continues around the world. A new research letter on the clinical characteristics of 13 patients sheds light on the nature of cases outside of Wuhan, China.